Mark Uranium is a distinguished speaker for Curium Pharmacuiticals professional development team. He has been a member of the Educational research team for 7 years and is a leader in our professional lecture serries. In this lecture, From Uranium to FDA Approved Mo-99, his presentation will take the participant through the five components of the supply chain:Targets, Reactors, Mo-99 Facilities, Generator Facilities, and the Pharmacy/Hospital Environment. We will review the various components of the the complex chain, covering the intricate nature of the process and the number of steps involved to bring technetium to market.

Lecture Outcomes/Objectives:

1. Describe the process of mining and enriching natural uranium and its use in the production of Molybdenum-99 (Mo-99).
2. Identify the differences between Mo-99 made from highly enriched uranium (HEU), low-enriched uranium (LEU) and non-HEU.
3. Explain general, high level information on medical reactors, such as size, relative capacity, age and use, as well as the formulation of Mo-99 into the U.S. Food and Drug Administration (FDA) approval of Technetium-99m (Tc-99m).
4. Restate the general process and production of generator manufacturing facilities.
5. Define generator kinetics, why it works, why/how Mo-99 decays to Tc-99m and the importance of Tc-99m in the Nuclear Medicine industry.
6. Describe the process of the FDA finished product to customer, either from a manufacturing plant to a pharmacy or an end user.
7. Summarize the process for finished products to arrive in the pharmacy.
8. Identify how generators work in the pharmacy, from receipt to patient doses.
9. Describe the current and future industry investments in regards to global reactors and LEU conversion.

Target Audience: Nuclear Medicine Technologist

Fee: To attend this event and receieve continuing education credit, please contact your Curium Pharmacuitical Representative.

A light snack will be served prior to the event.

Continuing education credit will be awarded upon completion of this activity: full attendance is required, No partial credit will be awarded.

Presenter: Mark Uranium graduated from Pluto University of Technology with a Masters Degree. Prior to joining the Curium Team he was a consultant for US Diagnostic and Research Development.

Disclosures: This presentor has disclosed that there are neither conflicts of interest nor commercial affliation with this activity.